Xizang Haisco Pharmaceutical Group Co Ltd
Haisco Pharmaceutical Group Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in China. The company offers pharmaceutical products in the areas of anesthesia and analgesia, diabetes mellitus and complications, tumor, neuralgia, parenteral nutrition, cardio-cerebrovascular, digestive and respiratory, narcotic analgesics, endocrine system, enteral parenteral,… Read more
Xizang Haisco Pharmaceutical Group Co Ltd (002653) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.009x
Based on the latest financial reports, Xizang Haisco Pharmaceutical Group Co Ltd (002653) has a cash flow conversion efficiency ratio of 0.009x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥39.68 Million) by net assets (CN¥4.23 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Xizang Haisco Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2024)
This chart illustrates how Xizang Haisco Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Xizang Haisco Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Xizang Haisco Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
AMP Limited
F:AMP
|
-0.012x |
|
Ningbo Ronbay New Energy Tech Ltd
SHG:688005
|
0.059x |
|
Morinaga Milk Industry Co. Ltd
F:MO8
|
N/A |
|
ArcBest Corp
NASDAQ:ARCB
|
0.034x |
|
Capital & Counties Properties PLC
PINK:CCPPF
|
0.010x |
|
Sinomach Heavy Equipment Group Co Ltd
SHG:601399
|
-0.020x |
|
Guangdong Aofei Data Technology Co Ltd Class A
SHE:300738
|
0.045x |
|
Hindustan Copper Limited
NSE:HINDCOPPER
|
0.144x |
Annual Cash Flow Conversion Efficiency for Xizang Haisco Pharmaceutical Group Co Ltd (2008–2024)
The table below shows the annual cash flow conversion efficiency of Xizang Haisco Pharmaceutical Group Co Ltd from 2008 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥4.20 Billion | CN¥442.05 Million | 0.105x | -2.42% |
| 2023-12-31 | CN¥4.17 Billion | CN¥449.58 Million | 0.108x | +257.26% |
| 2022-12-31 | CN¥3.13 Billion | CN¥94.55 Million | 0.030x | +146.11% |
| 2021-12-31 | CN¥2.92 Billion | CN¥35.80 Million | 0.012x | -83.03% |
| 2020-12-31 | CN¥2.85 Billion | CN¥206.21 Million | 0.072x | -77.54% |
| 2019-12-31 | CN¥2.38 Billion | CN¥764.26 Million | 0.322x | +35.70% |
| 2018-12-31 | CN¥1.99 Billion | CN¥472.61 Million | 0.237x | +19.17% |
| 2017-12-31 | CN¥1.97 Billion | CN¥391.81 Million | 0.199x | +5.68% |
| 2016-12-31 | CN¥2.26 Billion | CN¥426.11 Million | 0.188x | -8.40% |
| 2015-12-31 | CN¥2.16 Billion | CN¥443.03 Million | 0.205x | -13.86% |
| 2014-12-31 | CN¥2.11 Billion | CN¥502.57 Million | 0.238x | -19.15% |
| 2013-12-31 | CN¥1.93 Billion | CN¥568.41 Million | 0.295x | +8.40% |
| 2012-12-31 | CN¥1.71 Billion | CN¥464.75 Million | 0.272x | -19.89% |
| 2011-12-31 | CN¥767.76 Million | CN¥260.79 Million | 0.340x | -58.11% |
| 2010-12-31 | CN¥453.09 Million | CN¥367.38 Million | 0.811x | -70.23% |
| 2009-12-31 | CN¥135.17 Million | CN¥368.21 Million | 2.724x | +519.97% |
| 2008-12-31 | CN¥214.95 Million | CN¥94.45 Million | 0.439x | -- |